相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial
Vivek Shinde et al.
LANCET INFECTIOUS DISEASES (2022)
Prevalence, Genetics and Evolutionary Properties of Eurasian Avian-like H1N1 Swine Influenza Viruses in Liaoning
Hailing Li et al.
VIRUSES-BASEL (2022)
Epidemiology and Genotypic Diversity of Eurasian Avian-Like H1N1 Swine Influenza Viruses in China
Zhaomin Feng et al.
VIROLOGICA SINICA (2021)
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020
Mark W. Tenforde et al.
CLINICAL INFECTIOUS DISEASES (2021)
Distribution and evolution of H1N1 influenza A viruses with adamantanes-resistant mutations worldwide from 1918 to 2019
Weijun He et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Structural Characterization and Modeling of a Respiratory Syncytial Virus Fusion Glycoprotein Nanoparticle Vaccine in Solution
Susan Krueger et al.
MOLECULAR PHARMACEUTICS (2021)
Quadrivalent influenza nanoparticle vaccines induce broad protection
Seyhan Boyoglu-Barnum et al.
NATURE (2021)
Co-circulation of multiple influenza A reassortants in swine harboring genes from seasonal human and swine influenza viruses
Pia Ryt-Hansen et al.
ELIFE (2021)
The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
Wenqiang Sun et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Next-generation influenza vaccines: opportunities and challenges
Chih-Jen Wei et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Identification, Genetic Analysis, and Pathogenicity of Classical Swine H1N1 and Human-Swine Reassortant H1N1 Influenza Viruses from Pigs in China
Yafen Song et al.
VIRUSES-BASEL (2020)
Substantial Antigenic Drift in the Hemagglutinin Protein of Swine Influenza A Viruses
Pia Ryt-Hansen et al.
VIRUSES-BASEL (2020)
Evolution and Pathogenicity of the H1 and H3 Subtypes of Swine Influenza Virus in Mice between 2016 and 2019 in China
Yuzhong Zhao et al.
VIRUSES-BASEL (2020)
Protein-Based Nanoparticles as Drug Delivery Systems
Seyoung Hong et al.
PHARMACEUTICS (2020)
Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice
Bao-Yang Ruan et al.
VETERINARY MICROBIOLOGY (2020)
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Xiancai Ma et al.
IMMUNITY (2020)
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Alexandra C. Walls et al.
CELL (2020)
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
Jessica Marcandalli et al.
CELL (2019)
Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
Jin Gao et al.
MBIO (2019)
Continuous evolution of influenza A viruses of swine from 2013 to 2015 in Guangdong, China
Zhenpeng Cao et al.
PLOS ONE (2019)
Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans
Surender Khurana et al.
NATURE COMMUNICATIONS (2019)
Ferritin drug carrier (FDC) for tumor targeting therapy
Jiuyang He et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Comparison of adjuvants to optimize influenza neutralizing antibody responses
Rebecca S. Rudicell et al.
VACCINE (2019)
Molecular evolution of H1N1 swine influenza in Guangdong, China, 2016-2017
Mengkai Cai et al.
INFECTION GENETICS AND EVOLUTION (2018)
Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs
Bao-Yang Ruan et al.
VETERINARY MICROBIOLOGY (2018)
Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice
Tulin Morcol et al.
VACCINE (2017)
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M (TM) adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes
Gale Smith et al.
VACCINE (2017)
Epidemiological features of influenza circulation in swine populations: A systematic review and meta-analysis
Eugeniie Baudon et al.
PLOS ONE (2017)
Recombinant influenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane domain showed enhanced immunogenicity in mice and chicken
Yun Zhang et al.
SCIENTIFIC REPORTS (2017)
Immune efficacy of an adenoviral vector-based swine influenza vaccine against antigenically distinct H1N1 strains in mice
Yunpu Wu et al.
ANTIVIRAL RESEARCH (2017)
A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice
Yang Wang et al.
ANTIVIRAL RESEARCH (2017)
Swine Influenza Virus and Association with the Porcine Respiratory Disease Complex in Pig Farms in Southern Brazil
C. Schmidt et al.
ZOONOSES AND PUBLIC HEALTH (2016)
Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs
Luis A. Hernandez et al.
VETERINARY MICROBIOLOGY (2016)
A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages
Weibin Hu et al.
VACCINE (2015)
Continuing challenges in influenza
Robert G. Webster et al.
ANTIMICROBIAL THERAPEUTICS REVIEWS: INFECTIOUS DISEASES OF CURRENT AND EMERGING CONCERN (2014)
Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice
Qiliang Liu et al.
VACCINE (2014)
In vitro and ex vivo analyses of co-infections with swine influenza and porcine reproductive and respiratory syndrome viruses
I. Dobrescu et al.
VETERINARY MICROBIOLOGY (2014)
Recombinant influenza A H3N2 viruses with mutations of HA transmembrane cysteines exhibited altered virological characteristics
Jianqiang Zhou et al.
VIRUS GENES (2014)
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Masaru Kanekiyo et al.
NATURE (2013)
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production
Emanuele Montomoli et al.
EXPERT REVIEW OF VACCINES (2012)
2009 Pandemic Influenza A (H1N1) Pathology and Pathogenesis of 100 Fatal Cases in the United States
Wun-Ju Shieh et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Influenza Virus Evolution, Host Adaptation, and Pandemic Formation
Jeffery K. Taubenberger et al.
CELL HOST & MICROBE (2010)
Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005-2009
Vivek Shinde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
Rebecca J. Garten et al.
SCIENCE (2009)
The pathology of influenza virus infections
Jeffery K. Taubenberger et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Genetic evolution of swine influenza A (H3N2) viruses in China from 1970 to 2006
Hai Yu et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
分享论文
